Last reviewed · How we verify
NCT06871423
The Effect of Virtual Reality on Pain and Memory.
NA trial testing distraction in Healthy Adult in 16 participants. Completed in 1 March 2025.
1 March 2025
Quick facts
| Lead sponsor | University of Washington |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 16 |
| Start date | 3 January 2025 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- distraction
Conditions studied
- Healthy Adult — all drugs for Healthy Adult →
Sponsor
University of Washington
Who can join
18 and older, any sex, with Healthy Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The effect of Virtual Reality on pain and memory.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06871423
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of distraction
Trials testing the same drug.
- NCT06476418 — The Effect of Distraction During Blood Collection on the Fear and Anxiety Levels of Children · NA · completed
- NCT05693584 — The Effect of Using Virtual Reality Glasses on Pain During Fistula Cannulation in Hemodialysis Patients · NA · completed
- NCT03149263 — Evaluation of the Effect of the Presence Of Clowns on Pain and Anxiety Seen During Injections Botulinum Toxin in Child · completed
Other recruiting trials for Healthy Adult
Currently open trials in the same condition.
- NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
- NCT07393841 — Molecular Indicators of Systematic Fitness · recruiting
- NCT07343245 — A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs · Phase 1 · recruiting
- NCT07414862 — The Effects of Finger Extensor Training on Climbing Performance Compared With Traditional Flexor Training · NA · active not recruiting
- NCT07527247 — Improving Vaccine Protection for Older Adults · Phase 2 · recruiting
Other University of Washington trials
Trials by the same sponsor.
- NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
- NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
- NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
- NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
- NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06871423 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Washington
- Last refreshed: 13 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06871423.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing